BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34702266)

  • 1. Expression and prognostic potential of ribosome 18S RNA m
    Wang Z; Liu J; Yang Y; Xing C; Jing J; Yuan Y
    Cancer Cell Int; 2021 Oct; 21(1):569. PubMed ID: 34702266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment.
    Wang L; Peng JL
    Sci Rep; 2023 Jul; 13(1):10755. PubMed ID: 37400463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas.
    Sun S; Fei K; Zhang G; Wang J; Yang Y; Guo W; Yang Z; Wang J; Xue Q; Gao Y; He J
    Front Genet; 2020; 11():617174. PubMed ID: 33679869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression.
    Wang Q; Huang Y; Zhu Y; Zhang W; Wang B; Du X; Dai Q; Zhang F; Fang Z
    Cancer Med; 2024 Apr; 13(7):e7165. PubMed ID: 38613157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():803460. PubMed ID: 35186032
    [No Abstract]   [Full Text] [Related]  

  • 6. Mettl5 mediated 18S rRNA N6-methyladenosine (m
    Wang L; Liang Y; Lin R; Xiong Q; Yu P; Ma J; Cheng M; Han H; Wang X; Wang G; Liang F; Pei Z; Chen D; Yuan Q; Jiang YZ; Lin S
    Genes Dis; 2022 Jan; 9(1):268-274. PubMed ID: 35005123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribosome 18S m
    Huang H; Li H; Pan R; Wang S; Khan AA; Zhao Y; Zhu H; Liu X
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34970694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosome 18S m
    Rong B; Zhang Q; Wan J; Xing S; Dai R; Li Y; Cai J; Xie J; Song Y; Chen J; Zhang L; Yan G; Zhang W; Gao H; Han JJ; Qu Q; Ma H; Tian Y; Lan F
    Cell Rep; 2020 Dec; 33(12):108544. PubMed ID: 33357433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL5 promotes gastric cancer progression
    Zhang YQ; Li J; Qin Z; Li DM; Ye FZ; Bei SH; Zhang XH; Feng L
    World J Gastrointest Oncol; 2024 May; 16(5):1925-1946. PubMed ID: 38764837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL5-mediated 18S rRNA m
    Dai Z; Zhu W; Hou Y; Zhang X; Ren X; Lei K; Liao J; Liu H; Chen Z; Peng S; Li S; Lin S; Kuang M
    Mol Ther; 2023 Nov; 31(11):3225-3242. PubMed ID: 37735874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Level of Legumain Was Correlated With Worse Prognosis and Peritoneal Metastasis in Gastric Cancer Patients.
    Wang Y; Zhang S; Wang H; Cui Y; Wang Z; Cheng X; Li W; Hou J; Ji Y; Liu T
    Front Oncol; 2020; 10():966. PubMed ID: 32766126
    [No Abstract]   [Full Text] [Related]  

  • 12. The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma.
    Liu X; Ma H; Ma L; Li K; Kang Y
    Bioengineered; 2022 Mar; 13(3):5525-5536. PubMed ID: 35166644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of LOX Suggests Poor Prognosis in Gastric Cancer.
    Zhu J; Luo C; Zhao J; Zhu X; Lin K; Bu F; Yu Z; Zou F; Zhu Z
    Front Med (Lausanne); 2021; 8():718986. PubMed ID: 34595188
    [No Abstract]   [Full Text] [Related]  

  • 14. The METTL5-TRMT112 N
    Sepich-Poore C; Zheng Z; Schmitt E; Wen K; Zhang ZS; Cui XL; Dai Q; Zhu AC; Zhang L; Sanchez Castillo A; Tan H; Peng J; Zhuang X; He C; Nachtergaele S
    J Biol Chem; 2022 Mar; 298(3):101590. PubMed ID: 35033535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer.
    Zeng J; Li M; Shi H; Guo J
    Front Med (Lausanne); 2021; 8():672595. PubMed ID: 34291059
    [No Abstract]   [Full Text] [Related]  

  • 16. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():765569. PubMed ID: 35154268
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
    Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
    J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
    [No Abstract]   [Full Text] [Related]  

  • 18. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
    He XY; Zhao J; Chen ZQ; Jin R; Liu CY
    Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel m6A writer METTL5 as prognostic biomarker probably associating with the regulation of immune microenvironment in kidney cancer.
    Wei Zhang ; Chen Y; Zeng Z; Peng Y; Li L; Hu N; Gao X; Cai W; Yin L; Xu Y; Zhang X; Tang D; Dai Y
    Heliyon; 2022 Dec; 8(12):e12078. PubMed ID: 36619469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 18S rRNA m
    Xing M; Liu Q; Mao C; Zeng H; Zhang X; Zhao S; Chen L; Liu M; Shen B; Guo X; Ma H; Chen H; Zhang J
    EMBO Rep; 2020 Oct; 21(10):e49863. PubMed ID: 32783360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.